School of Medicine


Showing 1-3 of 3 Results

  • Marta Gaia Zanchi

    Marta Gaia Zanchi

    Lecturer, Surgery

    Bio I am the creator and Lead Director of the Byers Center for Biodesign's course and project immersion program "Biodesign for Mobile Health"? (BMH) examining the emerging mobile health industry (2012-present). This diverse, interactive, interdisciplinary, team and project-oriented course has been named by Stanford's Bioengineering "one of the flagship courses of our Department" and has trained nearly 200 students in a process of health technology innovation grounded on the understanding of contemporary Mobile Health needs.

    Currently Faculty member (Lecturer) at Stanford University in the School of Medicine, I am working with the Byers Center for Biodesign community under the direct supervision of Paul Yock, MD, Director of the Center and Founding Co-Chair of Stanford's Department of Bioengineering.

    In addition to my role as Faculty member and course Lead Director, I am a member of the Biodesign Leadership Group and a mentor to both Biodesign Fellows and students from the School of Medicine, all major Engineering schools and the Graduate School of Business. Together with a mHealth Advisory Group of thought leaders at Stanford, I help inform Stanford School of Medicine's thinking and strategy around Mobile Health to accelerate projects and foster quality research.

    Relevant links:
    Biodesign for Mobile Health (on Canvas): canvas.stanford.edu/courses/44010
    Byers Center for Biodesign: biodesign.stanford.edu/bdn/index.jsp

    At Stanford, I also have the pleasure to advise on the board of SHIFT, a student initiative aiming to promote and cultivate health innovation on campus by creating a forum for developers, entrepreneurs, and pre-health students to collaborate. A motivated leadership team envisions the group as a platform that connects and empowers students with resources and opportunities to innovate in healthcare. SHIFT fulfills its mission through open roundtable discussions, the TreeHacks Health hackathon and a fellowship program that pairs students as health++ fellows with early-stage companies or faculty-sponsored projects.

    Follow this link to learn more:
    SHIFT Health + Tech @Stanford: shift.stanford.edu

    When I am not at Stanford, you'll find me consulting, advising or otherwise engaging with and learning from the startup community of Silicon Valley. I am the Managing Director of Medinnovo LLC, advisory board (AB) member of many exciting privately-held companies, and founders' board of advisors (FBA) member at StartX MED, a startup accelerator.

    And, more links:
    My LinkedIN Profile: linkedin.com/in/mgzanchi
    Medinnovo LLC: medinnovo.com
    StartX Accelerator: startx.com

    Office Address:
    Marta Gaia Zanchi
    c/o Stanford Biodesign
    318 Campus Drive, Room E100
    Stanford, CA 93405-5428


    "Tell me and I forget, teach me and I may remember, involve me and I learn."
    ? Benjamin Franklin

  • Christopher K. Zarins

    Christopher K. Zarins

    Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery, Emeritus

    Current Research and Scholarly Interests Hemodynamic factors in atherosclerosis, pathogenesis of, aortic aneurysms, carotid plaque localization and complication, anastomotic intimal hyperplasia, vascular biology of artery wall, computational fluid dynamics as applied to blood flow and vascular disease.

  • Wei Zhou

    Wei Zhou

    Professor of Surgery (Vascular Surgery) at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests Dr. Zhou’s vascular research laboratory focuses on molecular mechanisms of and treatment strategies for intimal hyperplasia. Her specific clinical research interests are re-stenosis following endovascular interventions and outcome measures following carotid interventions. Through collaboration with Stanford investigators and investigators at Baylor College of Medicine, plaque morphology and radiographic imaging are correlated. Furthermore, innovational treatment approaches for cardiovascular diseases are investigated using a well-developed wire-injury rodent model. She is also the principle invetigator for several clinical trials that are funded by AHA and industries examining outcomes following cerebrovascular, aortic, and lower extremity interventions.

Footer Links:

Stanford Medicine Resources: